Your session is about to expire
← Back to Search
Enhanced Usual Care for Diabetes and Cognitive Health for Mild Cognitive Impairment (DREAM Trial)
DREAM Trial Summary
This trial will test if the DREAM program can help African Americans with poorly controlled diabetes and mild cognitive decline. The primary outcome is decline in verbal memory over 2 years, and follow-up data will be collected at 6, 12, 18, and 24 months.
DREAM Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowDREAM Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.DREAM Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have type 2 diabetes.Your HbA1c level is higher than 7.5.I am 65 years old or older.Your HbA1c level is higher than 7.5.I have type 2 diabetes.Your HbA1c level is higher than 7.5.I have been diagnosed with a specific type of memory loss affecting several areas.I have been diagnosed with a specific type of memory loss affecting several areas.I have had diabetes for at least one year.You are of African American descent.I have been diagnosed with a specific type of memory loss affecting several areas.You have dementia.You are of African American descent.I have type 2 diabetes.I have had diabetes for at least one year.Mental health conditionsMy health conditions do not exclude me from participating.Your doctor thinks you may have less than two years to live.I am 65 years old or older.
- Group 1: Diabetes Regulation for Eyesight and Memory (DREAM)
- Group 2: Enhanced Usual Care (EUC)
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How many participants is this trial recruiting?
"Affirmative. According to clinicaltrials.gov, the trial which was initially advertised on October 25th 2021 is still actively looking for 200 patients from a single medical facility. The post was last amended December 15th of this year."
Has the FDA certified Diabetes Regulation for Eyesight and Memory?
"The safety of Diabetes Regulation for Eyesight and Memory was rated a 2 due to the phase two status, meaning that efficacy has yet to be demonstrated in clinical trials but there is some safety data available."
Are there any available slots for prospective participants in this trial?
"Affirmative. Clinicaltrials.gov has data demonstrating that the medical experiment, which was first posted on October 25th 2021, is still recruiting participants. 200 people are needed to be enrolled from 1 centre of research."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger